GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cinclus Pharma Holding AB (OSTO:CINPHA) » Definitions » Other Financing

Cinclus Pharma Holding AB (OSTO:CINPHA) Other Financing : kr-58.18 Mil (TTM As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Cinclus Pharma Holding AB Other Financing?

Cinclus Pharma Holding AB's Other Financing for the three months ended in Sep. 2024 was kr1.63 Mil.

Cinclus Pharma Holding AB's Other Financing for the trailing twelve months (TTM) ended in Sep. 2024 was kr-58.18 Mil.


Cinclus Pharma Holding AB Other Financing Historical Data

The historical data trend for Cinclus Pharma Holding AB's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cinclus Pharma Holding AB Other Financing Chart

Cinclus Pharma Holding AB Annual Data
Trend Dec21 Dec22 Dec23
Other Financing
-0.13 -15.42 -0.17

Cinclus Pharma Holding AB Quarterly Data
Dec21 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Other Financing Get a 7-Day Free Trial Premium Member Only - - - -59.81 1.63

Cinclus Pharma Holding AB Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-58.18 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cinclus Pharma Holding AB Other Financing Related Terms

Thank you for viewing the detailed overview of Cinclus Pharma Holding AB's Other Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Cinclus Pharma Holding AB Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Kungsbron 1, Stockholm, SWE, SE-111 22
Cinclus Pharma Holding AB is a clinical stage pharmaceutical company developing a drug for the treatment of erosive gastroesophageal reflux diseases, and a dual therapy treatment with an antibiotic targeting Helicobacter pylori which is a bacteria that occurs in the gastric and duodenal mucosa. The Company's main target population is patients suffering from severe eGERD, where there is a lack of satisfactory treatment options.

Cinclus Pharma Holding AB Headlines

No Headlines